Literature DB >> 12586772

Defective activation of atypical protein kinase C zeta and lambda by insulin and phosphatidylinositol-3,4,5-(PO4)(3) in skeletal muscle of rats following high-fat feeding and streptozotocin-induced diabetes.

Yoshinori Kanoh1, Mini P Sajan, Gautam Bandyopadhyay, Atsushi Miura, Mary L Standaert, Robert V Farese.   

Abstract

UNLABELLED: Insulin-stimulated glucose transport in skeletal muscle is thought to be effected at least partly through atypical protein kinase C isoforms (aPKCs) operating downstream of phosphatidylinositol (PI) 3-kinase and 3-phosphoinositide-dependent protein kinase-1 (PDK-1). However, relatively little is known about the activation of aPKCs in physiological conditions or insulin-resistant states. Presently, we studied aPKC activation in vastus lateralis muscles of normal chow-fed and high-fat-fed rats and after streptozotocin (STZ)-induced diabetes. In normal chow-fed rats, dose-dependent increases in aPKC activity approached maximal levels after 15-30 min of stimulation by relatively high and lower, presumably more physiological, insulin concentrations, achieved by im insulin or ip glucose administration. Insulin-induced activation of aPKCs was impaired in both high-fat-fed and STZ-diabetic rats, but, surprisingly, IRS-1-dependent and IRS-2-dependent PI 3-kinase activation was not appreciably compromised. Most interestingly, direct in vitro activation of aPKCs by PI-3,4,5-(PO(4))(3), the lipid product of PI 3-kinase, was impaired in both high-fat-fed and STZ-diabetic rats. Defects in activation of aPKCs by insulin and PI-3,4,5-(PO(4))(3) could not be explained by diminished PDK-1-dependent phosphorylation of threonine-410 in the PKC-zeta activation loop, as this phosphorylation was increased even in the absence of insulin treatment in high-fat-fed rats.
CONCLUSIONS: 1) muscle aPKCs are activated at relatively low, presumably physiological, as well as higher supraphysiological, insulin concentrations; 2) aPKC activation is defective in muscles of high-fat-fed and STZ-diabetic rats; and 3) defective aPKC activation in these states is at least partly due to impaired responsiveness to PI-3,4,5-(PO(4))(3), apparently at activation steps distal to PDK-1-dependent loop phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586772     DOI: 10.1210/en.2002-221017

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.

Authors:  V Luna; L Casauban; M P Sajan; J Gomez-Daspet; J L Powe; A Miura; J Rivas; M L Standaert; R V Farese
Journal:  Diabetologia       Date:  2006-01-05       Impact factor: 10.122

2.  Insulin-stimulated plasma membrane association and activation of Akt2, aPKC zeta and aPKC lambda in high fat fed rodent skeletal muscle.

Authors:  Henry J Herr; Jeffrey R Bernard; Donald W Reeder; Donato A Rivas; Jose J Limon; Ben B Yaspelkis
Journal:  J Physiol       Date:  2005-03-31       Impact factor: 5.182

3.  Contrasting insulin dose-dependent defects in activation of atypical protein kinase C and protein kinase B/Akt in muscles of obese diabetic humans.

Authors:  L Casaubon; M P Sajan; J Rivas; J L Powe; M L Standaert; R V Farese
Journal:  Diabetologia       Date:  2006-10-07       Impact factor: 10.122

Review 4.  Cellular location of insulin-triggered signals and implications for glucose uptake.

Authors:  Nish Patel; Carol Huang; Amira Klip
Journal:  Pflugers Arch       Date:  2005-11-12       Impact factor: 3.657

5.  Insulin signaling and insulin sensitizing in muscle and liver of obese monkeys: peroxisome proliferator-activated receptor gamma agonist improves defective activation of atypical protein kinase C.

Authors:  Heidi K Ortmeyer; Mini P Sajan; Atsushi Miura; Yoshinore Kanoh; Jose Rivas; Yongxiang Li; Mary L Standaert; Alice S Ryan; Noni L Bodkin; Robert V Farese; Barbara C Hansen
Journal:  Antioxid Redox Signal       Date:  2010-11-23       Impact factor: 8.401

6.  The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity.

Authors:  Mini P Sajan; Mary L Standaert; Sonali Nimal; Usha Varanasi; Tina Pastoor; Stephen Mastorides; Ursula Braun; Michael Leitges; Robert V Farese
Journal:  J Lipid Res       Date:  2009-02-06       Impact factor: 5.922

7.  Atypical protein kinase C activity in the hypothalamus is required for lipopolysaccharide-mediated sickness responses.

Authors:  Joshua P Thaler; Sun Ju Choi; Mini P Sajan; Kayoko Ogimoto; Hong T Nguyen; Miles Matsen; Stephen C Benoit; Brent E Wisse; Robert V Farese; Michael W Schwartz
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

8.  Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes.

Authors:  Robert V Farese; Mini P Sajan; Hong Yang; Pengfei Li; Steven Mastorides; William R Gower; Sonali Nimal; Cheol Soo Choi; Sheene Kim; Gerald I Shulman; C Ronald Kahn; Ursula Braun; Michael Leitges
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

9.  Exercise improves phosphatidylinositol-3,4,5-trisphosphate responsiveness of atypical protein kinase C and interacts with insulin signalling to peptide elongation in human skeletal muscle.

Authors:  Christian Frøsig; Mini P Sajan; Stine J Maarbjerg; Nina Brandt; Carsten Roepstorff; Jørgen F P Wojtaszewski; Bente Kiens; Robert V Farese; Erik A Richter
Journal:  J Physiol       Date:  2007-05-31       Impact factor: 5.182

10.  Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes.

Authors:  Shicheng Cao; Bowen Li; Xuejie Yi; Bo Chang; Beibei Zhu; Zhenzhen Lian; Zhaoran Zhang; Gang Zhao; Huili Liu; He Zhang
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.